Tubal contraception and ovarian cancer risk: a global view.
Contraceptive Technology Innovation, FHI 360, 359 Blackwell St., Suite 200, Durham, NC 27701, USA. Electronic address: rcallahan@fhi360.org.
Rebecca L
RL
Callahan
Contraceptive Technology Innovation, FHI 360, 359 Blackwell St., Suite 200, Durham, NC 27701, USA.
Gregory S
GS
Kopf
Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
Jerome F
JF
Strauss
Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115; Dept. of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115.
Shelley S
SS
Tworoger
D003267:Contraception; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control; D011247:Pregnancy; D011274:Pregnancy, Tubal; D012307:Risk Factors; D058994:Salpingectomy; D013246:Sterilization, Tubal